Steph & Co’s Boston Scientific BSX Stock Holding History

Steph & Co’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-150	Closed	-$9.41K	–	290
2026 Q1	$9.41K	Sell	150 -105	-41%	-$8.4K	﹤0.01%	277
2025 Q4	$24.3K	Hold	255	–	–	0.01%	245
2025 Q3	$24.9K	Buy	+255	New	+$26.4K	0.01%	236

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Steph & Co's BSX Position: Q2 2026 in Review

Steph & Co sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 150 shares — an estimated $9.41K sold.

Steph & Co first reported a position in BSX in Q3 2025 and held it in 3 quarters. The position peaked at $24.9K in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Steph & Co reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Steph & Co sold 150 Boston Scientific shares in Q2 2026, an estimated $9.41K.
Steph & Co first reported a position in Boston Scientific in Q3 2025 and held it in 3 quarters.
Steph & Co's Boston Scientific position peaked at $24.9K in Q3 2025.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Steph & Co's 13F filing for Q2 2026, filed 16 Jul 2026.